Hydroxyzine Orifarm

Hydroxyzine Hydrochloride, the active ingredient in Hydroxyzine Orifarm, is a first‑generation antihistamine presented as an oral dosage form for oral use. It is indicated for relief of allergic symptoms, management of urticaria, and provides anxiolytic and sedative effects in appropriate clinical settings.

GNH USA supplies Hydroxyzine Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides full regulatory documentation to facilitate import, distribution and clinical use across global markets.

Hydroxyzine Orifarm, a first‑generation antihistamine, acts on peripheral H1 receptors to alleviate allergic and related conditions.

Allergic rhinitis: relief of nasal itching, sneezing and watery discharge. Urticaria (hives): reduction of wheal formation and itching. Anxiety and tension: provides short‑term anxiolytic effect and calming. Pre‑operative or post‑operative sedation: produces sedation to facilitate surgical procedures and recovery.

Hydroxyzine Orifarm may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: decreased salivation leading to oral discomfort. - Blurred vision: temporary difficulty focusing. - Constipation: slowed gastrointestinal motility.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with airway compromise. - Cardiac arrhythmia: irregular heart rhythm that may require monitoring. - Severe hypotension: marked drop in blood pressure causing dizziness or fainting.

When prescribing Hydroxyzine Orifarm, clinicians should consider several precautionary measures to ensure safe use.

Pregnancy: safety category unknown; use only if potential benefit justifies risk. Elderly: increased sensitivity to sedation and anticholinergic effects; monitor closely. Driving: patients should avoid operating machinery until they know how the drug affects them. Concomitant CNS depressants: use with caution due to additive sedative effects. Store at room temperature: keep in original packaging, protect from moisture and light.

Hydroxyzine Orifarm can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may cause severe hypotension and excessive sedation. - CNS depressants (e.g., benzodiazepines, opioids): additive central nervous system depression. - Anticholinergic drugs: heightened anticholinergic burden leading to confusion or urinary retention.

Moderate Interactions (Monitor Closely): - Alcohol: enhances drowsiness and impairment. - Antihypertensives: may potentiate blood pressure‑lowering effects. - Anticholinergic agents: monitor for increased dry mouth, constipation, and blurred vision.